| |
| |
|
| Insider
Information: |
Mcbarron Paul |
| Relationship: |
See Remarks, Director |
| City: |
Short Hills |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
33,378 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$13,017 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
33,378 |
|
|
| Total
Value |
$13,017 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cyclacel Pharmaceuticals Inc |
CYCC |
See Remarks, Director |
2023-12-21 |
33,378 |
2006-03-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYCC |
Cyclacel Pharmaceuticals ... |
See Remarks |
• • – |
2023-12-21 |
4 |
B |
$3.32 |
$6,252 |
D/D |
1,886 |
33,378 |
2.81 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
See Remarks |
• • – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
31,200 |
31,492 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
EVP, Finance, CFO, COO |
• • – |
2013-05-21 |
4 |
B |
$3.00 |
$39,213 |
D/D |
12,948 |
70,096 |
2.81 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
EVP, Finance, CFO, COO |
• • – |
2013-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
26,712 |
68,721 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
EVP, Finance, CFO, COO |
• • – |
2011-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
263,054 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
EVP, Finance, CFO, COO |
• • – |
2011-09-23 |
4 |
B |
$0.50 |
$6,000 |
D/D |
12,000 |
188,054 |
2.81 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
E.V.P., Finance & C.O.O. |
• • – |
2008-11-18 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
126,054 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
E.V.P., Finance & C.O.O. |
• • – |
2008-05-22 |
4 |
B |
$2.25 |
$4,388 |
D/D |
1,950 |
76,054 |
2.73 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
E.V.P., Finance & C.O.O. |
• • – |
2006-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
74,104 |
74,104 |
|
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
